Spur RST: Maximizing BTK CLTI Treatment Outcomes Without Compromising Safety
Physicians describe their experiences using the Spur Retrievable Scaffold followed by a DCB as a novel CLTI therapy that facilitates acute luminal gain, minimizes vessel recoil, and enhances drug delivery.
With Jos C. van den Berg, MD, PhD; Marcus Thieme, MD; Marianne Brodmann, MD; Leyla Schweiger, MD; and Thomas Zeller, MD
